Endocannabinoid receptor blockade reduces alanine aminotransferase in polycystic ovary syndrome independent of weight loss

BACKGROUND: Evidence suggests that endocannabinoid system activation through the cannabinoid receptor 1 (CB1) is associated with enhanced liver injury, and CB1 antagonism may be beneficial. The aim of this study was to determine the impact of rimonabant (CB1 antagonist) on alanine aminotransferase (...

Descripción completa

Detalles Bibliográficos
Autores principales: Dawson, Alison J., Kilpatrick, Eric S., Coady, Anne-Marie, Elshewehy, Abeer M. M., Dakroury, Youssra, Ahmed, Lina, Atkin, Stephen L., Sathyapalan, Thozhukat
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5512818/
https://www.ncbi.nlm.nih.gov/pubmed/28705172
http://dx.doi.org/10.1186/s12902-017-0194-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5512818/
https://www.ncbi.nlm.nih.gov/pubmed/28705172
http://dx.doi.org/10.1186/s12902-017-0194-2

Ejemplares similares